Morphochem Aktiengesellschaft für kombinatorische Chemie is a private clinical-stage pharmaceutical company located in Munich, Germany. Morphochem is a 100-percent subsidiary of Biovertis AG, headquartered in Vienna, Austria. Biovertis's major shareholder is TVM Capital Life Science.
Looking for a particular Morphochem AG employee's phone or email?
The Morphochem AG annual revenue was $9 million in 2026.
Peter Seufer-Wasserthal is the Vice President Business Development of Morphochem AG.
1 people are employed at Morphochem AG.
The NAICS codes for Morphochem AG are [325, 3254, 32, 32541].
The SIC codes for Morphochem AG are [28, 2834, 283].